The Bcl-2 protein expression was demonstrated to be associated with a high proliferative activity as measured by the S phase fraction in breast and colon cancers or the 3H thymidine labeling index in breast cancer [2,3,9]. This evidence concerns the gene BCL2 and malignant colon neoplasm.